Trials / Completed
CompletedNCT00292409
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2006-02-16
- Last updated
- 2013-11-08
Source: ClinicalTrials.gov record NCT00292409. Inclusion in this directory is not an endorsement.